Heart Disease Trial, Recruiting NCT07270536 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07270536
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and have given your written agreement before any screening tests begin
  • You are at least 18 years old
  • You have been diagnosed with heart failure where the heart's pumping strength is relatively preserved (sometimes called HFpEF), confirmed by specific heart tests and scoring systems (confirm with trial site for which scoring method applies to you)
  • You have a specific type of pacemaker (called a DDD pacemaker with LBB area pacing) that was implanted at least 12 weeks before a particular exercise test used in this study
  • You have been on the recommended medications for your type of heart failure (two specific drug types: an MRA and an SGLT2 inhibitor) for at least 6 weeks before the exercise test, unless your doctor has decided these are not suitable for you
  • Your heart is in a normal, steady rhythm (called sinus rhythm) at the time of your screening appointment and exercise test

Who may not be able to join:

  • You have significant lung disease, shown by breathing tests or lung scans
  • You have a serious heart valve problem that causes symptoms
  • You have severe high blood pressure in the lungs (confirm with trial site)
  • You have dangerous or unstable irregular heart rhythms
  • You have fainted repeatedly since having your pacemaker fitted
  • You have a permanent form of irregular heart rhythm called atrial fibrillation
  • You have a heart condition caused by abnormal protein build-up (amyloid cardiomyopathy)
  • You are physically unable to do exercise
  • You have been hospitalised for heart failure more than once in the past year
  • Your resting heart rate is above 100 beats per minute
  • At the time of the study tests, your heart failure is currently unstable or you have an unstable heart/chest condition
  • You have a medical reason why a line cannot safely be placed into a large vein in your neck — for example, a serious blood clotting problem, a local skin infection, a blocked vein, or a lung problem on the opposite side (confirm with trial site)
  • You have a medical reason why a line cannot safely be placed into an artery — for example, a blocked artery, a condition causing blood vessel spasms, an infection at the site, a serious clotting disorder, or poor blood flow in the hand (confirm with trial site)
  • You have a medical reason why you cannot safely do a supervised exercise test — for example, dangerous heart rhythm signs on an ECG, very low or very high blood pressure, fainting or dizziness, low blood oxygen levels, or dangerously high pressure in the heart during exercise (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +3216332211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Pulmonary capillary wedge pressure (PCWP), measured using a Swan-Ganz catheter (pulmonary artery catheter).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov